Two Sigma Advisers
DCPH

Two Sigma Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Two Sigma Advisers’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-401,200
Closed -$6.31M – 2738
2024
Q1 		$6.31M Sell
401,200
-31,200
-7% -$480K 0.01% 686
2023
Q4 		$6.97M Buy
432,400
+248,300
+135% +$3.17M 0.02% 671
2023
Q3 		$2.34M Sell
184,100
-131,700
-42% -$1.82M 0.01% 1112
2023
Q2 		$4.45M Sell
315,800
-159,900
-34% -$2.29M 0.01% 828
2023
Q1 		$7.35M Buy
475,700
+56,100
+13% +$937K 0.02% 651
2022
Q4 		$6.88M Buy
419,600
+113,700
+37% +$1.85M 0.02% 645
2022
Q3 		$5.66M Buy
305,900
+245,600
+407% +$3.85M 0.02% 677
2022
Q2 		$793K Buy
+60,300
New +$666K ﹤0.01% 1709
2021
Q1 		– Sell
-48,804
Closed -$2.79M – 2764
2020
Q4 		$2.79M Sell
48,804
-59,200
-55% -$3.51M 0.01% 1092
2020
Q3 		$5.54M Sell
108,004
-37,000
-26% -$1.81M 0.02% 728
2020
Q2 		$8.66M Buy
145,004
+36,100
+33% +$1.93M 0.03% 601
2020
Q1 		$4.48M Buy
+108,904
New +$6.05M 0.02% 749

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Two Sigma Advisers's DCPH Position: Q2 2024 in Review

Two Sigma Advisers sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 401,200 shares — an estimated $6.31M sold.

Two Sigma Advisers first reported a position in DCPH in Q1 2020 and held it in 12 quarters. The position peaked at $8.66M in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Two Sigma Advisers reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 401,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $6.31M.
  • Two Sigma Advisers first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 12 quarters.
  • Two Sigma Advisers's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $8.66M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.